SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-054568
Filing Date
2006-03-15
Accepted
2006-03-15 10:40:44
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1058609
2 FORM OF IDEMNIFICATION AGREEMENT dex104.htm EX-10.4 2609
3 SUBLEASE dex105.htm EX-10.5 70869
4 EXECUTIVE CHANGE OF CONTROL PLAN dex1033.htm EX-10.33 27568
5 2003 EXECUTIVE INCENTIVE PLAN dex1034.htm EX-10.34 11186
6 CONSENT OF KPMG LLP dex23.htm EX-23 2263
7 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9896
8 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9886
9 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4437
  Complete submission text file 0001193125-06-054568.txt   1198738
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 06687029
SIC: 2836 Biological Products, (No Diagnostic Substances)